Follow-up and surveillance of the lung cancer patient following curative-intent therapy

Chest

Volumn 123, Issue 1 SUPPL., 2003, Pages 272S-283S

  Colice, Gene L ^a   Rubins, Jeffrey ^b   Unger, Michael ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Lung cancer; Metachronous tumors; Recurrence; Surveillance

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CLINICAL TRIAL; FOLLOW UP; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SMOKING CESSATION; SURVIVAL TIME;

EID: 0037246734     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1_suppl.272S     Document Type: Article

References (91)

1. American Cancer Society. Cancer facts and figures 2001. Atlanta, GA: American Cancer Society
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-1717
3. Virgo KS, Johnson FE, Naunheim KS. Follow-up of patients with thoracic malignancies. Surg Oncol Clin N Am 1999; 8:355-369
4. Martini N, Melamed MR. Multiple primary lung cancers. Thorac Cardiovasc Surg 1975; 70:606-611
5. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer: adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997; 15:2996-3018
6. American College of Radiology. Follow-up of non-small cell lung cancer: appropriateness criteria. Reston, VA: American College of Radiology, 1999
7. National Comprehensive Cancer Network. Practice guidelines for non-small-cell lung cancer. Rockledge, PA: National Comprehensive Cancer Network, 2000
8. Association of Community Cancer Centers. Oncology patient management guidelines, version 3.0. Rockville, MD: Association of Community Cancer Centers, 2000
9. National Comprehensive Cancer Network. Practice guidelines for small-cell lung cancer. Rockledge, PA: National Comprehensive Cancer Network, 2000
10. Downey RJ, Martini N, Ginsberg RJ. Bronchogenic carcinoma. In: Johnson FE, Virgon KS, eds. Cancer patient follow-up. St. Louis, MO: Mosby, 1997; 226-230
11. Ichinose Y. Counterpoint. In: Johnson FE, Virgon KS, eds. Cancer patient follow-up. St. Louis, MO: Mosby, 1997; 230-232
12. Johnkoski JA, Wood DE. Counterpoint. In: Johnson FE, Virgon KS, eds. Cancer patient follow-up. St. Louis, MO: Mosby, 1997; 233-236
13. British Thoracic Society. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax 1998; 53(suppl):S1-S8
14. Handsy JR, Child AI, Grunkmeier GL, et al. Hospital readmissions after pulmonary resection: prevalence, patterns and predisposing characteristics. Ann Thoracic Surg 2001; 72:1855-1860
15. Nezu K, Kushibe K, Tojo T, et al. Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest 1998; 113:1511-1516
16. Katz J, Jackson M, Kavanagh BP, et al. Acute pain after thoracic surgery predicts long-term post-thoracotomy pain. Clin J Pain 1996; 12:55-60
17. Landreneau RJ, Mack MJ, Hazelrigg SR, et al. Prevalence of chronic pain after pulmonary resection by thoracotomy or video-assisted thoracic surgery. Thorac Cardiovasc Surg 1994; 107:1079-1086
18. Dajczman E, Gordon A, Kreisman H, et al. Long-term postthoracotomy pain Chest 1991; 99:270-274
19. Dales RE, Belanger R, Shamji FM, et al. Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 1994; 47:1443-1449
20. Barker WI, Langston HT, Naffah P. Postresectional spaces. Ann Thoracic Surg 1966; 2:299-310
21. Silver AW, Espinas EE, Byron FX. The fate of the postresection space. Ann Thoracic Surg 1966; 2:311-326
22. Suarez J, Clagett OT, Brown AL Jr. The postpneumonectomy space: factors influencing obliteration. J Thorac Cardiovasc Surg 1969; 57:539-542
23. Grillo HC, Shepard J, Mathisen DJ, et al. Postpneumonectomy syndrome: diagnosis, management, and results. Ann Thorac Surg 1992; 54:638-651
24. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy. J Clin Oncol 1990; 8:1543-1555
25. Curran WJ, Moldofsky PJ, Solin LJ. Quantitative analysis of the impact of radiation therapy field selection on post-RT pulmonary function. Int J Radiat Oncol Biol Phys 1988; 15:121
26. Choi NC, Kanarek DJ. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 1994; 10:S219-S230
27. Matthews MJ, Kanhouwa S, Pickren J, et al. Frequency of residual and metastatic tumor in patients undergoing surgical resection for lung cancer. Cancer Chemother Rep 1973; 4:63-67
28. Salerno CT, Frizell S, Nichans GA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 1998; 113: 1526-1532
29. Pantel K, Izibicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996; 347:649-653
30. Passlick B, Izibicki J, Kubuschok B, et al. Detection of disseminated lung cancer cells in lymph nodes. Ann Thorac Surg 1996; 61:177-183
31. Chen Z, Perez S, Holmes EC, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst 1993; 85:493-498
32. Immerman SC, Vanecko RM, Fry WA, et al. Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure. Ann Thorac Surg 1981; 32:23-26
33. Pairolero PC, Williams DE, Bergstralh EJ, et al. Postsurgical stage I bronchogenic carcinoma. Ann Thorac Surg 1984; 38:331-336
34. Iascone C, DeMeester TR, Albertucci M, et al. Local recurrence of resectable non-oat cell carcinoma of the lung. Cancer 1986; 57:471-476
35. The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1986; 205:67-71
36. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Thorac Cardiovasc Surg 1995; 109:120-129
37. Harpole DH, Herndon JE, Wolfe WG, et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. J Cancer Res 1995; 55:50-56
38. Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer; Lung Cancer Study Group. Ann Thorac Surg 1990; 49:242-247
39. Thomas P Jr, Rubinstein L. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer: Lung Cancer Study Group. J Thorac Cardiovasc Surg 1993; 106:1053-1058
40. Baldini EH, DeCamp MM, Katz MS, et al. Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer. Am J Clin Oncol 1999; 22:8-14
41. Poon RB. Lightening can strike twice. Chest 2000; 118:1526-1529
42. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90:1335-1345
43. Levi F, Randimbison L, Te VC, et al. Second primary cancers in patients with lung carcinoma. Cancer 1999; 86:186-190
44. Rosengart TK, Martini N, Ghosn P, et al. Multiple primary lung carcinomas. Ann Thorac Surg 1991; 52:773-779
45. Saito Y, Sato M, Sagawa M, et al. Multicentricity in resected occult bronchogenic squamous cell carcinoma. Ann Thorac Surg 1994; 57:1200-1205
46. Bechtel JJ, Petty TL, Saccomanno G. Five year survival and later outcome of patients with x-ray occult lung cancer detected by sputum cytology. Lung Cancer 2000; 30:1-7
47. Van Schil PEY, Riviere AB, Knaapen PJ, et al. Second primary lung cancer after bronchial sleeve resection. Thorac Cardiovasc Surg 1992; 104:1451-1455
48. Johnson BE, Ihde DC, Matthews MJ, et al. Non-small-cell lung cancer. Am J Med 1986; 80:1103-1110
49. Heyne KH, Lippman SM, Lee JJ, et al. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992; 10:1519-1524
50. Sagman U, Lishner M, Maki E, et al. Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol 1992; 10:1525-1533
51. Smythe WR, Estrera AL, Swisher SG, et al. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 2001; 71:962-966
52. Watanabe Y, Shimuzu J, Oda M, et al. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 1992; 26:73-78
53. Curran WJ, Herbert SH, Stafford PM, et al. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys 1992; 24:25-30
54. Green N, Kern W. The clinical course and treatment results of patients with postresection locally recurrent lung cancer. Cancer 1978; 42:2478-2482
55. Wu S, Lin Z, Xu C, et al. Multiple primary lung cancers. Chest 1987; 92:892-896
56. Van Bodegom PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: importance of long term follow up. Thorax 1989; 44:788-793
57. Deschamps C, Pairolero PC, Trastek VF, et al. Multiple primary lung cancers. Thorac Cardiovasc Surg 1990; 99:769-778
58. Westermann CJJ, van Swieten HA, Riviere AB, et al. Pulmonary resection after pneumonectomy in patients with bronchogenic carcinoma. Thorac Cardiovasc Surg 1993; 106:868-874
59. Antakli T, Schaefer RF, Rutherford JE, et al. Second primary lung cancer. Ann Thorac Surg 1995; 59:863-867
60. Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112:693-701
61. Asaph JW, Keppel JF, Handy JR, et al. Surgery for second lung cancers. Chest 2000; 118:1621-1625
62. Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60:1563-1572
63. Virgo KS, McKirgan LW, Caputo MCA, et al. Post-treatment management options for patients with lung cancer. Ann Surg 1995; 222:700-710
64. Younes RN, Gross JI, Deheinzelin D. Follow-up in lung cancer. Chest 1999; 115:1494-1499
65. Gilbert S, Reid KR, Lam MY, et al. Who should follow up lung cancer patients after operation? Ann Thorac Surg 2000; 69:1696-1700
66. Virgo KS, Naunheim KS, McKirgan LW, et al. Cost of patient follow-up after potentially curative lung cancer treatment. Thorac Cardiovasc Surg 1996; 112:356-363
67. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. J Gen Intern Med 1997; 12:318-331
68. Westeel V, Choma D, Clement F, et al. Relevance of an intensive postoperative follow-up after surgery for non-small lung cancer. Ann Thorac Surg 2000; 70:1185-1190
69. Pujol J, Demoly P, Daures J, et al. Chest tumor response measurement during lung cancer chemotherapy. Am Rev Respir Dis 1992; 148:1149-1154
70. Gorich J, Beyer-Enke SA, Flentje M, et al. Evaluation of recurrent bronchogenic carcinoma by computed tomography. Clin Imaging 1990; 14:131-137
71. Libshitz HI, Sheppard DG. Filling in of radiation therapy-induced bronchiectatic change. Radiology 1999; 210:25-27
72. Naunheim KS, Virgo KS, Coplin MA, et al. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg 1995; 60:1612-1616
73. Johnson FE, Naunheim KS, Coplin MA, et al. How practice patterns in lung cancer patient follow-up are affected by surgeon age. Oncol Rep 1996; 3:851-855
74. Johnson FE, Naunheim KS, Coplin MA, et al. Geographic variation in the conduct of patient surveillance after lung cancer surgery. J Clin Oncol 1996; 14:2940-2949
75. Johnson FE, Naunheim KS, Coplin MA, et al. How tumor stage affects surgeons' surveillance strategies after lung cancer surgery. Chest 1997; 111:99-102
76. Virgo KS, Naunheim KS, Coplin MA, et al. Lung cancer patient follow-up. Chest 1998; 114:1519-1534
77. Shields TW. Postoperative lung cancer surveillance. Chest 1997; 111:11-12
78. Lowe VJ, Naunheim KS. Positron emission tomography. Ann Thorac Surg 1998; 65:1821-1829
79. Lowe VJ, Naunheim KS. Current role of positron emission tomography in thoracic oncology. Thorax 1998; 53:703-712
80. Kubota K, Yamada S, Ishiwata K, et al. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up of cases of lung cancer. Clin Nucl Med 1992; 17:877-881
81. Patz EF, Lowe VJ, Hoffman JM, et al. Persistent or recurrent bronchogenic carcinoma. Radiology 1994; 191:379-382
82. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793
83. Duhaylongsod FG, Lowe VJ, Patz EF, et al. Detection of primary and recurrent lung cancer by means of F-18 fluoro-deoxyglucose positron emission tomography (FDG PET). Thorac Cardiovasc Surg 1995; 110:130-140
84. Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999; 14:1376-1380
85. Patz EF, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR Am J Roentgenol 2000; 174:769-774
86. Stieber P, Zimmermann A, Reinmiedl J, et al. CYFRA 21-1 in the early diagnosis of recurrent disease in nonsmall cell lung carcinomas. Anticancer Res 1999; 19:2665-2668
87. Niho S, Nishiwaki Y, Goto K, et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer. Lung Cancer 2000; 27:159-167
88. Weigel TL, Kosco PJ, Dacic S, et al. Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. Ann Thorac Surg 2001; 71:967-970
89. Gritz ER, Nisenbaum R, Elashoff RE, et al. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control 1991; 2:105-112
90. Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small cell lung cancer is associated with fewer smoking related second primary cancers. Ann Intern Med 1993; 119:383-390
91. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small cell lung cancer. J Natl Cancer Inst 1997; 89:1782-1788